Skip to main content

Table 2 Eradication rates of the study population.

From: Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

 

Intention to Treat

 

Per Protocol

 

UBT

QT

OAR

CI 95%

QT

OAR

CI 95%

Negative

38 (70.4%)

20 (40.4%)

p = 0.009

37 (77.1%)

20 (46.5%)

p = 0.003

Positive

16 (29.6%)

25 (55.6%)

 

11 (22.9%)

23 (53.5%)

 

N

54

45

OR 1.58 (1.1–2.29)

48*

43

OR 1.65 (1.1–2.36)

  1. * One patient achieved eradication without having completed the treatment programme
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us